Medical device maker Medtronic plcMDT recently announced the receipt of FDA approval for its Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator (CRT-D) SureScan device for the treatment ...
Study Supplements Earlier Data Showing Reduction in Hospital Readmissions for Heart Failure Patients with AdaptivCRT Technology MINNEAPOLIS, USA and NICE, FRANCE - New data from the Medtronic, Inc.
Please provide your email address to receive an email when new articles are posted on . Among the features of the new European Society of Cardiology guideline on pacing and cardiac resynchronization ...
PLATINIUM, released simultaneously in both Europe and Japan by LivaNova (formerly Sorin Group), will protect patients from avoidable replacement surgeries and the inherent risk of complications.
LONDON, LivaNova PLC a market-leading medical technology company, announced today the launch of PLATINIUM, its next-generation range of implantable cardiac defibrillators (ICDs) and cardiac ...
“This new device platform provides a number of new features that will help me to improve management of my patients with ICD and CRT-D devices, while delivering new safety features on top of St. Jude ...
NEW YORK/CHICAGO, June 23 (Reuters) - Early intervention with Boston Scientific Corp's implantable devices, called cardiac resynchronization therapy, can slow the progression of heart failure, ...
A combination defibrillator and cardiac resynchronization device reduced deaths by nearly one-third in patients with mild heart failure in a study that was terminated early on Monday because of its ...
RMH electrophysiologist Robert VerNooy, MD, has successfully implanted a new type of heart pacing device that helps doctors better treat patients diagnosed with heart failure. He is the first ...
CHICAGO, IL — Almost nine in 10 patients implanted with defibrillators who were also eligible for cardiac resynchronization therapy (CRT) actually did receive the pacing therapy in a US nationwide ...
On the heels of a unanimous FDA panel recommendation in March for an expanded indication of Boston Scientific's (Natick, Massachusetts) cardiac resynchronization therapy defibrillators (CRT-Ds), ...
March 6, 2009 (Washington, DC) — In a national registry for patients with implantable cardioverter-defibrillators (ICDs), among those also eligible for cardiac resynchronization therapy (CRT), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results